TY - JOUR
T1 - Clinicopathologic comparisons between estrogen receptor‐positive and ‐negative gastric cancers
AU - Wu, Chew‐Wun ‐W
AU - Tsay, Shyh‐Haw ‐H
AU - Chang, Tai‐Jay ‐J
AU - Chang, Hway‐May ‐M
AU - Hsieh, Mao-Chih
AU - Lui, Wing‐Yiu ‐Y
AU - P'Eng, Fang‐Ku ‐K
AU - Chi, Chin‐Wen ‐W
PY - 1992/1/1
Y1 - 1992/1/1
N2 - We report that a modified dextran‐coated charcoal (DCC) assay, including the addition of sodium molybdate and 5% DCC stripping of endogenous hormone, detected higher estrogen receptors (ERs) than those by the conventional assay. ERs in 21 gastric adenocarcinoma were determined by the modified DCC assay; 13 patients had ERs of 2.5 to 520.2 fmol/mg protein with a mean dissociation constant of 1.9 × 10×10 M. The remaining 8 patients had no detectable amount of the receptor. There were no differences between the ER‐positive and ER‐negative groups in clinico‐pathologic characteristics such as age, sex, tumor size, location, gross appearance, invasive depth, invasion of lymph vessel or vein of stomach wall, nodal involvement, peritoneal dissemination, liver metastasis, and curability. Histological analysis, using Japanese, Lauren's, or Ming's classifications, all revealed no differences between the ER‐positive and ‐negative groups. The survival rate was identical for the 2 study groups. These results suggest that the presence or absence of ERs in gastric adenocarcinoma does not correlate to either biologic or clinicopathologic characteristics of this tumor; the role of ERs in human gastric cancer remains to be elucidated. © 1992 Wiley‐Liss, Inc.
AB - We report that a modified dextran‐coated charcoal (DCC) assay, including the addition of sodium molybdate and 5% DCC stripping of endogenous hormone, detected higher estrogen receptors (ERs) than those by the conventional assay. ERs in 21 gastric adenocarcinoma were determined by the modified DCC assay; 13 patients had ERs of 2.5 to 520.2 fmol/mg protein with a mean dissociation constant of 1.9 × 10×10 M. The remaining 8 patients had no detectable amount of the receptor. There were no differences between the ER‐positive and ER‐negative groups in clinico‐pathologic characteristics such as age, sex, tumor size, location, gross appearance, invasive depth, invasion of lymph vessel or vein of stomach wall, nodal involvement, peritoneal dissemination, liver metastasis, and curability. Histological analysis, using Japanese, Lauren's, or Ming's classifications, all revealed no differences between the ER‐positive and ‐negative groups. The survival rate was identical for the 2 study groups. These results suggest that the presence or absence of ERs in gastric adenocarcinoma does not correlate to either biologic or clinicopathologic characteristics of this tumor; the role of ERs in human gastric cancer remains to be elucidated. © 1992 Wiley‐Liss, Inc.
KW - dextran‐coated charcoal assay
KW - gastric cancer
KW - sodium molybdate
UR - http://www.scopus.com/inward/record.url?scp=0026483453&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026483453&partnerID=8YFLogxK
U2 - 10.1002/jso.2930510406
DO - 10.1002/jso.2930510406
M3 - Article
C2 - 1434653
AN - SCOPUS:0026483453
SN - 0022-4790
VL - 51
SP - 231
EP - 235
JO - Journal of Surgical Oncology
JF - Journal of Surgical Oncology
IS - 4
ER -